Magdi Gindi
Family Medicine · Los Angeles, CANPI 1700821329
Payments from drug & device makers
Across 260 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$866
- AstraZeneca$531
- GSK$444
- Novo Nordisk$245
- Bayer$237
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,657100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,285 |
| Lilly USA, LLC | 40 | $866 |
| AstraZeneca | 24 | $531 |
| GSK | 23 | $444 |
| Novo Nordisk | 12 | $245 |
| Bayer | 11 | $237 |
| Shield Therapeutics Inc | 8 | $204 |
| Pfizer | 8 | $179 |
| Ardelyx, Inc. | 6 | $176 |
| Ironwood Pharmaceuticals, Inc | 7 | $164 |
| Boehringer Ingelheim | 7 | $159 |
| Electromed, Inc. | 7 | $140 |
| Vivus LLC | 6 | $132 |
| Aimmune Therapeutics, Inc. | 5 | $120 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Novartis | 3 | $57 |
| Merck | 3 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $48 |
| Sanofi | 1 | $47 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Optos, Inc. | 2 | $38 |
| Amgen | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Dexcom, Inc. | 2 | $29 |
| Exact Sciences | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 1 | $28 |
| Hikma Pharmaceuticals USA | 1 | $23 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Alk-abello, Inc | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$5,657 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naftifine Hcl | 12 | $2,883 |
| Lubiprostone | 12 | $2,068 |
| Clobetasol Propionate | 14 | $1,588 |
| Ketoconazole | 30 | $1,329 |
| Fluocinonide | 12 | $581 |
| Memantine Hcl ErMemantine Hcl | 12 | $576 |
| Levetiracetam | 14 | $201 |
| Gabapentin | 20 | $194 |
| Potassium Chloride | 13 | $132 |
| Losartan Potassium | 23 | $94 |
| Ibandronate Sodium | 11 | $91 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 13 | $83 |
| Simvastatin | 36 | $76 |
| Triamcinolone Acetonide | 13 | $65 |
| Atorvastatin Calcium | 38 | $64 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Los Angeles
- Albert NassirLos Angeles$5.7M
- Nader SobhLos Angeles$4.1M
- Alexander RivkinLos Angeles$2.8M
- Pamela KushnerLos Angeles$1.2M
- Scott HowellLos Angeles$793K
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.